Filter & sort
The latest funding rounds from the UK tech ecosystem. Updated 16 October 2026.
Announcements
65
Total raised
£646M
disclosed amounts
Morgan Stanley led the seed round to support platform expansion and data science development.
"Despite 90% of the UK’s 33.8 million female population experiencing monthly hormonal symptoms, women’s health has for too long been fragmented and underserved. Unfabled has already empowered thousands of women to find effective treatments for common, yet hugely disruptive, hormonal and reproductive conditions like PMS, Polycystic Ovary Syndrome (PCOS), endometriosis and menopause."
IW Capital led the Series A round to support team growth and international scaling.
"We’re pleased to be investing in Plumm as the company continues to grow in the UK and internationally. At IW Capital, we focus on backing businesses that are doing important work in growing markets, and it was clear that Plumm is well poised to expand their offering, having built a great platform to serve the underserved and expanding mental health market. We are thrilled to be working with Plumm on the next stage of their growth journey."
The financing round was led by Superbet Ventures with participation from Hellen's Rock and Animoca Brands.
"We are excited to become strategic investors, convinced by the vision of GoJoe’s founders. They are exactly the type of start-up that we are looking for in the venture capital market. Having an unique and highly scalable business model, found at the cross-roads of wellbeing, sports and social apps, GoJoe has an impressive potential of organic growth with a wide range of demographics."
Steven Bartlett's Flight Fund has backed the personalised nutrition company in a new deal.
"Once in a while I come across a company that truly has the potential to move the world forward in a profound way. It takes a great team, with a bold vision and a well executed product roadmap to do so. That is exactly what I found in ZOE. It's a company that represents the future – health science, driven by big data, that enables us to extend not just our life-span, but more importantly our health span. I'm deeply proud to be an investor and now an ambassador of a company that I truly believe will change the world by leading the nutrition-science revolution."
Octopus Ventures led the Series B financing to support product innovation and marketing growth.
"Our mission was to create a game-changing, personalised skincare brand to democratise dermatology. I’ve now moved on to my next D2C venture and I’m delighted the team is doing such a good job delivering that vision to hundreds of thousands of people,"
